+ Product Pathways
- All Targets
- Angiogenesis/Tyrosine Kinase
- Cell Cycle/Checkpoint
- HDAC
- Apoptosis
- PARP
- Aurora/Ksp
- MAPK
- PI3K/Akt/mTOR
- Hormone
- Integrase/CCR5
- Proteases/HSP90/HSP70
- Wnt/Hedgehog/Notch
- Jak/Stat
- Ca/cAMP/Lipid Signaling
- Neuro Signaling
- TGF-beta/Smad Signaling
- GPCR
- Ion channel
- Cytochrome P450
- Others
- Cancer
- Infection
- Endocrinology
- Metabolic Disease
- Inflammation
- Immunology
- Neurological Disease
- Cardiovascular Disease
Phosphoinositide 3 kinase
| Cat.No. | Product Name | Feedback | Added |
|---|---|---|---|
| S2636 | A66 | Jul 2011 | |
| A66 is a highly specific and selective p110α inhibitor with IC50 of 32,30 and 43 nM for p110α, p110α/E545K, p110α/H1047R, respectively. | |||
| S2671 | AS-252424 | Aug 2011 | |
| AS-252424 is a potent and selective PI3k γ inhibitor with IC50 of 33 and 935 nM for PI3Kγ and PI3Kα, respectively. | |||
| S2681 | AS-604850 | Aug 2011 | |
| AS-604850 is a selective, ATP-competitive PI3Kγ inhibitor with IC50 of 0.25, >20, >20, and 4.5 µM for the human recombinant γ, δ, β, and α isoforms, respectively. | |||
| S1410 | AS-605240 | Jul 2010 | |
| AS-605240 is a PI3K γ inhibitor (IC50 at 8 nM). | |||
| S1462 | AZD6482 | Aug 2010 | |
| AZD6482 is a PI3Kβ inhibitor (IC50=0.021μM) used in antithrombotic therapy. | |||
| S1009 | BEZ235 (NVP-BEZ235) | Apr 2009 | |
| BEZ235 (NVP-BEZ235) is a dual ATP-competitive phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR) inhibitor with an IC50 of 4, 5, 7 and 75 nM for p110α, p110γ, p110δ and p110β, respectively. | |||
| S2247 | BKM120 (NVP-BKM120) | May 2011 | |
| BKM120 (NVP-BKM120) is a bioavailable specific oral pan-class I phosphatidylinositol 3-kinase (PI3K) kinase inhibitor. | |||
| S2226 | CAL-101 | Apr 2011 | |
| CAL-101 is a potent PI3K p110δ inhibitor with an IC50 of 65 nM. | |||
| S2682 | CAY10505 | Aug 2011 | |
| CAY10505 is a potent PI3Kγ inhibitor with an IC50 of 30 nM. | |||
| S2699 | CH5132799 | Nov 2011 | |
| CH5132799 is a novel and selective class I PI3K inhibitor with IC50 of 0.014, 0.12, 0.5, 0.036, 5.3 and 1.6 μM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, PI3K C2β and mTOR, respectively. | |||
| S2675 | D-106669 | Aug 2011 | |
| D-106669 is a highly selective PI3K inhibitor with a submicromolar inhibition. | |||
| S2676 | D-87503 | Aug 2011 | |
| D-87503 is a potent PI3K/Akt/mTOR signaling pathway inhibitor with IC50 of 62nM and 0.76μM for PI3K and Erk2, respectively. | |||
| S1065 | GDC-0941 | Jun 2009 | |
| GDC-0941 is an inhibitor of Class I PI3 Kinase,p110a IC50=0.003uM,U87MG IC50=0.95μM. | |||
| S2696 | GDC-0980 (RG7422) | Nov 2011 | |
| GDC-0980 (RG7422) is a selective, dual PI3 Kinase and mTOR Kinase inhibitor with IC50 of 5, 27, 7, and 14 nM for PI3Kα, β, δ, and γ, respectively. | |||
| S1360 | GSK1059615 | Jun 2010 | |
| GSK1059615 is a pan-PI3K reversible inhibitor,IC50:PI3Kα(0.4 nM), β (0.6 nM),γ (5 nM),δ (2 nM) and mTOR(12 nM). | |||
| S2658 | GSK2126458 | Aug 2011 | |
| GSK2126458 is a highly potent PI3K and mTOR inhibitor with an app Ki of 19 pM for PI3K. | |||
| S1268 | IC-87114 | Jun 2010 | |
| IC-87114 was the first isoform-selective PI3K inhibitor : p110δ(IC50 = 0.13 µM) vs. p110α(IC50 = 200 µM), p110β(IC50 = 16 µM) and p110γ(IC50 = 61 µM). | |||
| S1105 | LY294002 | Aug 2009 | |
| PI3k inhibitor (cell IC50 about 10 μM) and a casein kinase II inhibitor. | |||
| S2638 | NU7441 | Aug 2011 | |
| NU7441 is a potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor with IC50 of 0.01, 1.7 and 5 μM for DNA-PK, mTOR and PI 3-K, respectively. | |||
| S2743 | PF-04691502 | Jan 2012 | |
| PF-04691502 is a potent and selective dual PI3K/mTOR inhibitor to phosphorylation of AKT T308 and AKT S473 with IC50 of 7.5 and 3.8 nM, respectively. | |||
| S1038 | PI-103 | Apr 2009 | |
| PI-103 is a potent, cell-permeable, ATP-competitive PI3K family members inhibitor with IC50 of 2, 8, 20, 26, 48, 83, 88, 150 nM for DNA-PK, p110α, mTORC1, PI3-KC2β, p110δ, mTORC2, p110β, and p110γ, respectively. | |||
| S2207 | PIK-293 | Feb 2011 | |
| PIK-293 is a PI3-K inhibitor.PIK-293 inhibit the p110α, p110β, p110δ, and p110γ with IC50 of 100uM,25uM,0.24uM,and 10uM. | |||
| S2227 | PIK-294 | Apr 2011 | |
| PIK-294 is a highly selective p110 inhibitor with an IC50 of 3 nM. | |||
| S1187 | PIK-90 | Apr 2010 | |
| PIK-90 is a PI3K inhibitor,IC50=11, 350, 18, and 58 for p110 α, β, γ and δ isoforms. | |||
| S1489 | PIK-93 | Sep 2010 | |
| PIK-93 is a PI4KIIIβinhibitor (IC50 at 19 nM). | |||
| S2739 | PKI-402 | Nov 2011 | |
| PKI-402 is a selective, reversible, ATP-competitive, equipotent class I phosphatidylinositol 3-kinases (PI3K) inhibitor with IC50 of 1, 7, 16 and 14 nM for PI3Kα, PI3Kβ, PI3Kγ and PI3Kδ, respectively. | |||
| S2628 | PKI-587 | Jul 2011 | |
| PKI-587 is a highly potent dual PI3K/mTOR kinase inhibitor with IC50 of 0.4 nM and <0.1 μM for PI3K-α and mTOR, respectively. | |||
| S2622 | PP121 | Jun 2011 | |
| PP121 is a multitargeted dual receptor tyrosine kinases inhibitor with IC50 of 0.052, 1.4, 0.15, 1.1, 0.06, 0.01and 0.002 μM for p110α, p110β, p110δ, p110γ, DNA-PK, mTOR and PDGFR, respectively. | |||
| S2391 | Quercetin(Sophoretin) | Feb 2011 | |
| Quercetin is a PI3K and PKC inhibitor with IC50 of 3.8 μM and 15µg/ml. | |||
| S1352 | TG100-115 | Jun 2010 | |
| TG100–115 is a PI3K γ and -δ inhibitor (IC50 = 83 and 235 nM, respectively) | |||
| S1169 | TGX-221 | Mar 2010 | |
| TGX-221 is a PI3Kβ(C50=10nM). | |||
| S1118 | XL147 | Sep 2009 | |
| XL147 is a selective inhibitor of Class I PI3K isoforms. | |||
| S1523 | XL765 | Oct 2010 | |
| XL765 is a mixed mTOR/PI3k inhibitor with IC50 of 157, 39, 113, 9 and 43 nM for mTOR, p110α, β, γ and δ, respectively. | |||
| S1072 | ZSTK474 | Jun 2009 | |
| ZSTK474 is an inhibitor of PI3K γ(IC50 at 6 nM). | |||
Buy Now / Print Quote
Find Multiple Products by Catalog Number
Customer's Feedback
| Dongfeng Chen, The Rausing Lab |
| "Your product U0126(Cat.NO S1102) works well in our experiments. I hope I can get more excellent products from your company in future." |
| R.B. Cambridge |
| "I have used the chemical that I bought from you(Selleck,PTC-124) and it worked well.So we will eventually be ordering more." |
| Zhenghe John Wang Assistant Professor, Case Western Reserve University |
| "We have purchased LBH-589, Saha and MS-275 from you and they all worked well." |
| Jenny Sun |
| "We used the LBH-589 in our experiments. The compound is easy to use with excellent reproducibility." |
| Yu Wang, Harvard University |
| "The GDC0449 compound worked very well. The results in my hands are equally good as what's been published. Thanks for this great resource for our research." |
| Dung-Fang Lee |
| "Based on our preliminary data, I found MLN8237 and VX-680 have good effects in inhibiting Aurka-maintaining ESC self-renewal in mouse ES cells." |
Latest Catalog
| May 2010 Selleck Latest Catalog | ![]() |

